Antengene : Xpovio Approved In Hong Kong For Relapsed And/or Refractory Multiple Myeloma Treatment
17/7 03:02
(RTTNews) - Antengene Corporation Limited said that the Department of Health, the Government of the Hong Kong Special Administrative Region has approved a New Drug Application for Xpovio (selinexor), applicable in combination with dexamethasone, for the treatment of adult patient...